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Abstract: 
 
GH represses its own secretion via rapid and reversible feedback exerted at key hypothalamic 
loci. The primary mechanisms include stimulation of somatostatin release and inhibition of 
GHRH outflow. Autoinhibition is prominent in the adult male rat but diminutive in the female 
animal. The sex contrast reflects important differences in central neuropeptide signaling in this 
species. No comparable insights into gender-specific control of GH autofeedback are available in 
the human. To examine this issue, we quantitated acute recombinant human (rh)GH-induced 
inhibition of baseline (resting) and aerobic exercise-stimulated GH secretion in healthy young 
men (n = 8) and early follicular-phase women (n = 6). Each subject underwent four fasting, 
morning inpatient infusion studies in a prospectively randomized, placebo-controlled, double-
blind, within-subject cross-over design. The feedback paradigm comprised 6-min bolus iv 
infusion of saline or rhGH (10 μg/kg) followed in 120 min by rest or submaximal aerobic 
(individually calibrated) bicycle ergometry for 30 min. Concomitantly, blood was sampled every 
10 min for 6 h, and sera were submitted to immunochemiluminometric GH assay (sensitivity 
0.005 μg/liter). Biexponential deconvolution analysis was applied to estimate stimulated GH 
secretory-burst mass (μg/liter per 90 min after onset of exercise or rest). Women and men had 
statistically comparable serum estradiol but unequal testosterone concentrations. Repeated-
measures ANOVA documented a significant three-way interaction among gender, stimulus type 
(rest or exercise), and feedback status (saline or rhGH injection) in determining GH secretory-
burst mass (P = 0.008). There were prominent two-factor interactions among gender and exercise 
(P < 0.001); gender and rhGH-induced negative feedback (P = 0.002); and exercise and rhGH 
feedback (P = 0.006). Gender comparisons disclosed that women, compared with men, maintain 
20-fold higher GH secretory-burst mass at rest (P < 0.001); 40-fold less stimulation of pulsatile 
GH release by exercise than rest (P < 0.001); and 20-fold greater inhibition of GH secretory-
burst mass by rhGH than saline at rest (P < 0.05). Observed feedback contrasts by sex were 
specific, inasmuch as gender did not affect absolute estimates of exercise-stimulated GH 
secretion (μg/liter/90 min); nadir GH concentrations (μg/liter) enforced by rhGH infusion; and 
the time latency (min) to manifest maximal inhibition after rhGH injection. 
 
In summary, the present clinical investigation unmasks: 1) markedly greater fractional feedback 
inhibition of pulsatile GH secretion by rhGH in young women than men; and 2) partial resistance 
of the aerobic-exercise stimulus to GH autofeedback in both women and men. We postulate that 
sex-steroid-specific control of somatostatin and GHRH outflow may mediate the former gender 
contrasts, whereas unknown (gender-independent) factors may determine the capability of 
exercise to significantly antagonize GH autoinhibition. 
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Article:  
 
The pulsatile mode of GH secretion is the principal (>85%) component of GH production in 
healthy individuals (1, 2). Discrete secretory bursts are stimulated by GHRH, putatively 
amplified by endogenous ghrelin, and inhibited by somatostatin and IGF-I (3–7). In addition, a 
pulse of GH exerts rapid autonegative feedback via cognate receptors in the hypothalamus before 
inducing a detectable rise in systemic IGF-I concentrations (8–12). Mechanistic analyses in the 
adult male rat indicate that GH autofeedback drives periventricular somatostatin release and 
represses arcuate-nucleus GHRH outflow (1, 2, 13). Dissipation of the GH pulse relieves 
heightened somatostatin secretion and triggers rebound-like GHRH release, thereby putatively 
inducing the next GH secretory burst (1, 2). According to this experimental platform, cycles of 
reversible autoinhibition drive recurrent high-amplitude pulses (12, 14). Pulsatile GH output 
induces masculine patterns of growth and target-tissue gene expression in the rodent (8, 15, 16). 
 
The amplitude of GH pulses and the efficacy of GH autofeedback differ vividly by sex in the 
laboratory rodent (1, 2). In particular, the adult female rat maintains low-amplitude GH pulses 
and exhibits significant resistance to autoinhibition, whereas the male animal generates high-
amplitude GH bursts and manifests strong GH autofeedback (17). On the other hand, whether or 
how gender determines GH autoregulation in the human is not known. A gender contrast, if 
present clinically, may differ diametrically from that observed in the experimental animal. This 
consideration arises because the amplitude of GH concentration peaks and the mass of GH 
secreted per burst are consistently higher in women than comparably aged men (18–21). Recent 
biomathematical modeling paradigms forecast that endogenous renewal of high-amplitude GH 
secretory bursts requires recurrent cycles of autofeedback (12, 14). If valid in the human, this 
precept would predict that GH-autofeedback efficacy is greater in women than men. 
 
Acute aerobic exercise evokes prominent GH secretion in the young adult (22). Gender 
comparisons indicate that low-intensity (but not maximal aerobic) exercise stimulates greater GH 
release in young women than men (23–29). The mechanisms subserving this sex difference are 
not known. However, the exercise stimulus may be unique in partially overcoming endogenous 
 
 Abbreviations: GHRP, GH-releasing peptide; rh, recombinant human; S, saline; VO2 peak, peak oxygen 
consumption. 
GH autofeedback. In fact, two or three consecutive bouts of exercise fail to damp subsequent GH 
pulsatility (30–32). 
 
Based on the foregoing issues, the present study tests the interlinked hypotheses that gender 
governs susceptibility to controlled acute GH-specific autonegative feedback in the healthy 
young adult and that the exercise stimulus is relatively resistant to rhGH-enforced autoinhibition, 
especially in women. 
 
Subjects and Methods 
 
Clinical protocol 
 
Volunteers provided a detailed medical history and underwent a complete physical examination, 
after giving written informed consent approved by the Institutional Review Board. Inclusion 
criterion comprised healthy young adults who undertook recreational aerobic exercise three or 
four times per week. Eight men and six women participated. Characteristics were (men) age 26 ± 
0.5 yr, height 181 ± 1.0 cm, weight 82 ± 1.6 kg, and peak oxygen consumption (VO2 peak) 44 ± 
1.2 ml/kg·min; and (women) age 22 ± 0.5 yr, height 164 ± 1.0 cm, weight 60 ± 1.2 kg, and 
VO2 peak 32 ± 1.6 ml/kg·min. Exclusion criteria included pregnancy, breast-feeding, age 35 yr 
or more, steroid or hormone use, substance abuse, clinical depression, acute or chronic systemic 
illness, endocrinopathy, hepatorenal disease, diabetes mellitus, anemia (hematocrit < 38%), 
exposure to neuro- or psychoactive medications within five biological half-lives, recent 
transmeridian travel, shift work, weight gain or loss (exceeding 6 pounds in the preceding 6 wk), 
and failure to provide informed consent. 
 
The lactate threshold was estimated in each volunteer in a preliminary session by graded bicycle 
ergometry, as reported earlier (28). Thereby, the intensity of the subsequent 30-min exercise 
stimulus was set at an a priori constant load midway between that associated with the individual 
lactate threshold and volitional fatigue (VO2 peak). Total work and expended calories (per 
nonprotein respiratory exchange ratio) were calculated in each 30-min exercise session. Heart 
rate and blood lactate concentrations were assessed every 10 min during exercise. In resting 
sessions, subjects remained supine. 
 
Autonegative feedback paradigm 
 
Women were studied during the early follicular phase (d 2–8) once or twice (and no more often 
than three times) in a single menstrual cycle. Volunteers were admitted to the General Clinical 
Research Center (GCRC) on four separate occasions (two rest and two exercise) in prospectively 
randomized order at least 2 d apart. To obviate nutritional confounds, participants ingested a 
constant meal at 1800 h the evening before, which contained 500 kcal (60% carbohydrate, 20% 
protein, and 20% fat). Subjects then remained fasting overnight and until 1330 h the next day. 
Use of coffee, alcohol, and tobacco was disallowed in the GCRC. 
 
Figure 1 schematizes the paradigm of saline vs. recombinant human (rh)GH infusion and 
rest vs. exercise applied here. To allow simultaneous sampling and infusion, two forearm venous 
catheters were inserted contralaterally at 0600 h. Blood samples (1.5 ml) were withdrawn every 
10 min for a total of 6 h from 0730 to 1330 h. After a 30-min baseline, a single dose of rhGH (10 
μg/kg) or saline (S) was infused iv as a 6-min squarewave pulse. Thereafter, blood was sampled 
every 2.5 min for 10 min (0800–0810 h) and every 5 min for 50 min (0810–0900 h) for kinetic 
analyses, followed by every 10 min for 4.5 additional h (0900–1330 h). Exercise was initiated 
120 min after double-blind iv injection of saline or rhGH (1000–1030 h). This feedback 
paradigm suppresses spontaneous and GHRH and GH-releasing peptide (GHRP)-2-stimulated 
GH secretion by approximately 2-fold in the adult (9, 33). 
 
 
Figure 1. Schema of combined infusion, exercise and sampling protocol to quantitate rhGH-
induced feedback inhibition of resting and exercise-stimulated GH secretion in young women 
and men. Fasting subjects received an iv infusion of S or rhGH (10 μg/kg over 6 min) at time 30 
min to enforce autonegative feedback. Endogenous GH release was stimulated 120 min later by 
rest or aerobic exercise. Blood was withdrawn at 10-min intervals for a total of 6 h beginning 30 
min before S/rhGH injection. 
 
Assays 
 
GH concentrations were measured in duplicate in each sample by ultrasensitive 
immunochemiluminescence assay (Nichols Institute, San Juan Capistrano, CA) (34, 35). The 
double-monoclonal antibody configuration detects predominantly 22-kDa GH with 34% cross-
reactivity with 20-kDa GH (36). Sensitivity is 0.005 μg/liter at three SDs above the zero-dose 
tube. No samples in the present study contained less than 0.015 μg/liter GH. The median 
intraassay and interassay coefficients of variation are 5.8% and 6.7%, respectively. For 
deconvolution analysis (below), the concentration-dependence of the intraassay variance was 
modeled as a power function using replicates contained in the entire set of samples from all four 
admissions in any given subject (see Deconvolution Analysis, below). Concentrations of total 
testosterone and estradiol were quantitated by solid-phase RIA (Diagnostic Products, Los 
Angeles, CA) on the four fasting 0800 h sera collected in each subject. Mean intra- and 
interassay coefficients of variation were, respectively, 6.9 and 8.3% (total testosterone) and 5.9 
and 9.1% (estradiol) (37). 
 
Deconvolution analysis 
 
Pulsatile GH secretion was quantitated by multiparameter deconvolution analysis (38, 39). The 
outcome measure is the summed mass of GH secreted in bursts (μg/liter per 90 min) after onset 
of the rest or exercise intervention. The deconvolution technique used published biexponential 
kinetics of endogenous GH disappearance in healthy adults, i.e. a rapid-phase half-life of 3.5 
min, a slow-phase half-life of 20.8 min, and a fractional (slow/total) decay amplitude of 0.63 
(40). The deconvolution procedure accounts for unequal within-session basal (nonpulsatile) GH 
secretion, overlapping GH pulses, and continued decay of GH concentrations across the 
observational interval (41, 42). The foregoing approach obviates technical confounding of 
secretion estimates due to use of only the absolute peak, incremental peak, and/or integrated GH 
concentration (28, 39, 43). The same methodology was used to estimate GH kinetics over the 
120 min including and after injection of rhGH, except that the slow-phase (second) component 
of biexponential decay was estimated analytically in each session. The distribution volume of 
exogenous GH (liters per kilogram) was computed as the quotient of the dose (10 μg/kg) and the 
deconvolution-calculated mass of infused rhGH (micrograms per liter). 
 
Statistical procedures 
 
Statistical comparisons of the derived measure, GH secretory-burst mass, were made on 
logarithmically transformed data to limit heterogeneity of variance. The model was three-way (2 
× 2 × 2 factorial) repeated-measures ANOVA (44). This structure includes each of gender (two 
factors), rest or exercise (two factors), and S or rhGH injection (two factors). Thereby, we 
examined overall significance of a three-way effect and key two-way interactions, viz. gender 
and negative feedback (primary hypothesis); feedback and exercise (corollary postulate); and, 
gender and exercise (incidental) as putative determinants of induced GH release. Parameters of 
the statistical model were estimated by restricted maximum likelihood. Post hoc contrasts in 
means were based on Fisher’s restricted least significantly different criterion with an overall 
(experiment-wise) type I error rate of 0.05 (45). For statistical purposes, the relative response 
(fold-effect of stimulated over placebo or fold-difference by gender) is represented as the 
geometric mean ratio with 95% statistical confidence intervals. Absolute GH secretory-burst 
mass (μg/liter per 90 min) is cited as the arithmetic mean ± SEM. 
 
Results 
 
Fasting resting (saline-infused) 6-h integrated serum GH concentrations averaged 940 ± 248 
(809) and 454 ± 153 (251) μg/liter × min in women and men, respectively (P < 0.05). Fasting 
(0800 h) concentrations (mean of four admissions/subject) of testosterone (nanograms per 
deciliter) were 47 ± 8 and 589 ± 44 (P < 0.001) and estradiol (picograms per milliliter) 40 ± 4 
and 25 ± 4 (P = NS) in women and men, respectively. 
 
Figure 2 depicts mean 6-h GH concentration-time series (micrograms/liter) obtained by 10-min 
sampling before, during, and after injection of S or rhGH at rest and after exercise in women 
(Fig. 2A) and men (Fig. 2B). Insets (right) show an expanded y-axis scale to visualize 
suppressed GH concentrations due to time-delayed inhibition by injected rhGH. 
 
ANOVA disclosed a significant three-factor interaction among gender, exercise, and rhGH 
infusion in determining GH secretory-burst mass (P = 0.008). Further statistical analyses 
revealed two-factor interactions among gender and exercise (P < 0.001); gender and rhGH 
feedback (P = 0.002); and exercise and rhGH feedback (P = 0.006). 
 
 
Fig. 2. Mean (±SEM) GH concentrations (y-axis) monitored every 10 min before, during, and 
after iv infusion of S or rhGH (time 30 min, x-axis) followed by rest or aerobic exercise (time 
150 min, boldface arrow). Data are given separately in healthy young women (A) and men (B). 
Expanded y-axis insets (right) show suppressed GH concentrations after rhGH infusion during 
the stimulus interval of rest or exercise [150–370 min after the onset of blood sampling (Fig. 1)]. 
Each value is the cohort-specific mean ± SEM (n = 6 women, n = 8 men). 
 
Figure 3 summarizes absolute estimates (±SEM) of GH secretory-burst mass 
(micrograms/liter/90 min) and Fig. 4, A and B, the relative (fold) (and 95% statistical confidence 
intervals) responses to exercise and rhGH. Post hoc statistical contrasts (protected at overall 
experiment-wise P < 0.05) revealed that at rest: (a) during saline infusion, women maintained a 
20-fold (95% confidence interval 5.8, 66) higher absolute mass of GH secreted in bursts than 
men (P < 0.001; Fig. 3); and (b) rhGH (compared with S) infusion suppressed GH secretory-
burst mass in women by 51-fold (8, 329; P ≤ 0.001) and in men by 2.6-fold (1.4, 5.0; P = 
0.008; Fig. 4A). According to these outcomes, women at rest are approximately 20-fold more 
susceptible to fractional autoinhibition by rhGH of GH burst mass than men at rest (P < 0.05). 
Absolute maximal suppression of GH release was comparable by gender; viz. nadir GH 
concentrations (micrograms per liter) induced by rhGH infusion were 0.15 ± 0.027 (0.13) and 
0.14 ± 0.046 (0.12) in women and men, respectively (Fig. 3, upper). The timing of the nadir 
(minutes after the rhGH injection) was similar in women [315 ± 14 (325)] and men [321 ± 11 
(340)]. 
 
 
Fig. 3. Deconvolution-based quantitation of the mass of GH secreted in pulses (micrograms per 
liter per 90 min) at rest (top) and after exercise (bottom) after iv infusion of S or rhGH. Absolute 
nadir serum GH concentrations (micrograms per liter) induced by S and rhGH infusion at rest are 
summarized in the upper right subpanel. Data are the mean ± SEM (n = 8 men, n = 6 
women). P values denote gender contrasts. P = NS defines P > 0.05. 
 
After S infusion, aerobic exercise stimulated burst-like GH secretion by 1.8 (0.3, 11)-fold in 
women (P = NS) and 75 (35, 120)-fold in men (P < 0.001) over that observed at rest (P < 0.05 
by gender; Fig. 4B). Mean exercise-induced absolute GH secretory-burst mass (micrograms per 
liter per 90 min; Fig. 3, lower) was similar in women and men. Simple peak GH concentrations 
(micrograms per liter) were also independent of gender at 21 ± 4.1 (women) and 18 ± 5.7 μg/liter 
(men) (P = NS, see Materials and Methods caveat). 
 
 
Fig. 4. A, Relative (fold-) suppression of GH secretory-burst mass by injection of rhGH, 
compared with S at rest (left) and in response to acute aerobic exercise (right). Values are the 
mean (and 95% statistical confidence intervals). B, Relative (fold-) stimulatory effect of 
exercise, compared with rest, on the mass of GH secreted after iv infusion of S or rhGH (Fig. 1). 
 
Compared with sequential saline infusion and exercise, consecutive rhGH injection and exercise 
reduced GH secretory-burst mass by 3.2 ± 1.1 (2.2)-fold in women (P = 0.043) and 2.1 ± 0.39 
(1.9)-fold and men (P = 0.049) (P = NS by gender). Thus, significant negative feedback operates 
during exercise. However, despite prior injection of rhGH, exercise stimulated GH secretion 
markedly, compared with the rhGH/rest intervention in both women and men (Fig. 3, lower). In 
fractional terms, rhGH/exercise increased GH secretory-burst mass by 90-fold (12, 374) (P < 
0.001) in women and 98-fold (48, 150) (P < 0.001) in men (P = NS by gender) over that 
observed after rhGH/rest; Fig. 4B). Absolute GH secretory-burst mass after sequential rhGH 
injection and exercise did not differ by gender (Fig. 3). 
 
The slow-phase half-life of decay of injected rhGH (based on within-subject means of two 
determinations) was 20 ± 1.64 (19) min in women and 18 ± 0.74 (18) min in men (P = NS). The 
estimated distribution volume of infused GH (milliliters per kilograms) was 59 ± 8.2 (61) in 
women and 62 ± 9.3 (63) in men [P = NS]. The lack of a gender difference in apparent 
distribution volume is relevant because GH secretory-burst mass is expressed as micrograms GH 
released per unit distribution volume (liter). 
 
Table 1 summarizes exercise-associated work completed, kilocalories expended (per nonprotein 
respiratory exchange ratio), and end-exercise VO2 in men and women. Men completed more 
work, expended more energy, and maintained higher end-exercise VO2 than women (each P < 
0.01). Bolus iv infusion of 10 μg/kg rhGH before exercise did not alter any of the foregoing 
measures. 
 
TABLE 1. Total work, kilocalories expended, and end-exercise VO2 in men and women 
   
Total work (kJ)  Total kcal  End-exercise VO2 (liter/min)  End-exercise %  
Mena  Women  Mena  Women  Mena  Women  Men  Women  
Saline  326 ± 35  163 ± 26  418 ± 36  215 ± 29  2.9 ± 0.2  1.4 ± 0.2  84 ± 23  73 ± 13  
rhGH (10 μg/kg)  319 ± 38  163 ± 26  413 ± 34  205 ± 25  2.8 ± 0.2  1.5 ± 0.2  82 ± 23  72 ± 10  
a P < 0.005 by gender; P > 0.05 for each comparison of the within-gender response to saline vs. rhGH infusion (n = 8 
men; n = 6 women). 
 
Discussion 
 
The present clinical investigation is unique in examining composite control of pulsatile GH 
secretion by gender, autonegative feedback, and aerobic exercise in healthy young adults. 
Statistical comparisons established that all three of gender, GH autofeedback, and exercise 
jointly determine GH secretory-burst mass. Specifically, gender and GH autoinhibition, gender 
and exercise, and GH autorepression and exercise interact significantly as paired determinants of 
GH secretory-burst mass. Post hoc analyses disclosed three salient gender-related contrasts, 
wherein: 1) women maintain higher absolute GH secretory-burst mass at rest than men; 2) 
women sustain markedly greater rhGH-induced fractional suppression of GH secretion at rest 
than men; and 3) men manifest greater fractional stimulation by exercise (over rest) than women. 
The foregoing gender-related distinctions are specific in that women and men did not differ by 
way of absolute nadir GH concentrations enforced by GH autofeedback; the time delay to 
maximal feedback inhibition; the absolute mass of GH secreted after exercise with or without 
GH autofeedback; and the half-life or distribution volume of infused rhGH. 
 
The precise mechanisms mediating gender-related control of GH autofeedback are not known. 
The mean serum estradiol concentration was similar in young men and in women evaluated in 
the early follicular phase of the menstrual cycle, whereas the total testosterone concentration was 
12-fold higher in men. A plausible postulate is that gender-related differences in in 
situ hypothalamo-pituitary synthesis of estradiol and/or reduced androgen from available 
testosterone substrate modulates autofeedback actions in the GH axis. If the basic mechanisms 
that transduce GH-specific feedback drive of somatostatin outflow and reciprocal repression of 
GHRH release are analogous among species (1, 2, 17, 46), then a reasonable conjecture is that a 
pulse of (exogenous) GH stimulates somatostatin secretion more and/or inhibits GHRH secretion 
less in young women than comparably aged men (Fig. 5). 
 
The genesis of higher amplitude GH pulses (and higher mean serum GH concentrations) in 
women than men is not established (47). In experimental contexts, recovery from GH 
autofeedback requires concomitant somatostatin withdrawal and rebound (burst-like) GHRH 
secretion (1, 2, 11, 15, 16, 48). Analogously in biomathematical models, negative feedback that 
enforces a prominent valley is followed by burst-like release of GHRH and GH. Such cycles are 
able to sustain recurrent, self-renewing, high-amplitude pulses of GH (12, 49) (see first part of 
text). In clinical contexts, GH pulse amplitude in the female exceeds that in the male throughout 
late puberty, young adulthood, and menopause (18–21) and doubles in the preovulatory phase of 
the menstrual cycle (50, 51). Collectively, these observations suggest that sex steroids modulate 
autofeedback-dependent pulsatile GH secretion. 
 
 
Fig. 5. Simplified schema of hypothesized mechanisms mediating gender-related contrasts in 
GH-induced autoinhibition. 
 
The 20-folder greater mass of GH secreted per burst in fasting women than men studied at rest 
(Fig. 3) is consistent with an earlier report of approximately 70-fold higher single-random serum 
GH concentrations in fasting ambulatory young women than men, as determined by high-
sensitivity immunofluorometric assay (52). Twenty-four-hour integrated GH concentrations and 
GH secretion rates are often 2-fold higher in women than men (18–21). Whereas near-maximal 
(present data) or maximal aerobic exercise stimulates GH secretion equally by gender (53), low-
intensity exercise elicits greater GH release in women than men (27, 29). The present inference 
that fractional GH autofeedback is potentiated in women, compared with men, is concordant 
with each of the foregoing gender contrasts (27, 29, 47, 52, 53). 
 
Investigations of sex steroid-dependent regulation of pulsatile GH release have unveiled specific 
mechanisms by which estrogen per se augments the amount of GH secreted per burst. For 
example, in postmenopausal women, short-term supplementation with oral estradiol, compared 
with placebo: 1) blunts suppression of GH release by low doses of somatostatin-14 (54); 2) 
amplifies submaximal stimulation by rhGHRH-1,44-amide (55); 3) potentiates near-maximal 
drive by GHRP-2; and 4) attenuates rhGH-induced feedback on GHRP-2 (but not the resting, 
exercise or GHRH)-evoked GH secretion (33, 49). Far less is known about the central 
neuropeptidyl actions of testosterone in the human somatotropic axis. In principle, actions of 
testosterone would depend on relative in situ hypothalamo-pituitary conversion to estradiol 
(stimulatory) or 5 α-reduced testosterone (inactive or slightly inhibitory) (1, 47, 56). 
 
A recent clinical analysis disclosed 2- to 3-fold greater GH-specific fractional feedback 
repression and rebound-like recovery GH secretion in midpubertal than prepubertal boys or 
young men (9). Comparable quantitation of postsuppression rebound GH release was not 
possible during the present sampling duration. However, absolute maximal suppression (nadir 
serum GH concentrations) did not differ by gender. This finding could indicate that rhGH-
induced stimulation of maximal somatostatin outflow and/or concomitant inhibition of GHRH 
release is comparable in women and men. 
 
The present study shows that near-maximal aerobic exercise significantly opposes exogenous 
GH autoinhibition in both women and men. In fact, despite enforced GH feedback, exercise 
induced a 90- to 98-fold increase in pulsatile GH release over that observed after rhGH injection 
at rest. Nonetheless, compared with exercise alone, rhGH infusion suppressed the exercise 
response significantly (by 2.1- to 3.2-fold) and equivalently by gender. Therefore, feedback 
resistance is partial, rather than complete. The current data potentially explain the apparent 
absence of response down-regulation during successive bouts of exercise (30–32). If GH 
autoinhibition is mediated by stimulation of somatostatin release and inhibition of GHRH 
outflow (first part of text), then aerobic exercise may overcome autoinhibition by muting 
somatostatin and/or augmenting GHRH release. The present data do not distinguish between 
these two mechanisms or exclude the operation of both. 
 
In summary, in the absence of an exercise stimulus, young women exhibit significantly greater 
susceptibility to fractional inhibition by rhGH-induced autofeedback than men. According to 
current regulatory concepts, this sex contrast would be consistent with gender-associated 
modulation of GH-specific stimulation of somatostatin and/or repression of GHRH secretion. On 
the other hand, women and men manifest marked (but not complete) resistance of the exercise 
stimulus to GH autoinhibition. Further studies will be required to elucidate putatively central 
neuropeptidyl interactions that mediate the foregoing gender distinctions and transduce 
substantial feedback resistance by exercise. 
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